<DOC>
	<DOCNO>NCT01984788</DOCNO>
	<brief_summary>The purpose study determine whether BCX4161 give daily oral prophylactic treatment safe effective reduce number acute attack patient hereditary angioedema .</brief_summary>
	<brief_title>Safety Efficacy Oral BCX4161 Prophylactic Treatment HAE</brief_title>
	<detailed_description />
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Angioedemas , Hereditary</mesh_term>
	<criteria>Key Written inform consent Clinical laboratory diagnosis Hereditary Angioedema Type I II An average angioedema attack frequency 1/week Acceptable birth control measure Key Concurrent use define treatment prophylaxis Pregnancy breastfeed Clinically significant medical condition , laboratory abnormality medical history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Oral Prophylaxis</keyword>
</DOC>